Clinical Trial Update: RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD [Phase 4]

View source ↗

Summary

A Phase 4 trial update comparing dabigatran to warfarin in atrial fibrillation patients with type 2 diabetes and chronic kidney disease. The status is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dabigatran (Dabigatran etexilate)
• Warfarin (warfarin)

Snippet

Sponsor: Irina Ermolaeva | Conditions: Atrial Fibrillation, T2DM (Type 2 Diabetes Mellitus) | Phase 4 | Status: UNKNOWN